Global Magnetic Resonance Elastography (MRE) Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033

Global Magnetic Resonance Elastography (MRE) Market Segmentation, By Application (Hepatic Magnetic Resonance Elastography, Breast Magnetic Resonance Elastography, Brain Magnetic Resonance Elastography, Skeletal Muscle Magnetic Resonance Elastography, and Others), End User (Hospitals, Diagnostic Imaging Centers, Research Institutes, and Others)- Industry Trends and Forecast to 2033

Magnetic Resonance Elastography (MRE) Market Size

• The global Magnetic Resonance Elastography (MRE) market size was valued at USD 6.61 billion in 2025and is expected to reach USD 12.53 billion by 2033, at a CAGR of 8.33% during the forecast period
• The market growth is primarily driven by the increasing prevalence of chronic liver diseases, fibrosis, and cancer-related conditions, alongside the growing demand for non-invasive diagnostic imaging technologies in healthcare facilities worldwide
• Furthermore, continuous advancements in MRI technology, expanding adoption of precision diagnostics, and rising preference for accurate tissue stiffness assessment are positioning magnetic resonance elastography as a preferred imaging solution across hospitals and diagnostic centers. These combined factors are significantly accelerating the growth of the magnetic resonance elastography (MRE) industry

Magnetic Resonance Elastography (MRE) Market Analysis

• Magnetic Resonance Elastography (MRE), a non-invasive imaging technique used to measure tissue stiffness and detect abnormalities in organs such as the liver, breast, and brain, is becoming increasingly important in modern diagnostic imaging due to its high accuracy, reproducibility, and ability to support early disease detection
• The rising demand for Magnetic Resonance Elastography (MRE) is primarily driven by the increasing prevalence of chronic liver diseases, neurological disorders, and cancer-related conditions, along with the growing preference for non-invasive diagnostic procedures among healthcare providers and patients
• North America dominated the Magnetic Resonance Elastography (MRE) market with the largest revenue share of 41.3% in 2025, supported by advanced healthcare infrastructure, widespread adoption of MRI technologies, and the strong presence of leading medical imaging companies, with the U.S. experiencing notable growth in MRE procedures due to rising awareness regarding early diagnosis and advancements in imaging systems
• Asia-Pacific is expected to be the fastest growing region in the Magnetic Resonance Elastography (MRE) market during the forecast period due to increasing healthcare investments, rising patient population, and expanding access to advanced diagnostic imaging technologies
• Hepatic Magnetic Resonance Elastography segment dominated the Magnetic Resonance Elastography (MRE) market with a market share of 47.6% in 2025, driven by the growing use of MRE for non-invasive assessment and monitoring of liver fibrosis, cirrhosis, and other chronic liver disorders across hospitals and diagnostic centers

Report Scope and Magnetic Resonance Elastography (MRE) Market Segmentation

Magnetic Resonance Elastography (MRE) Market Trends

“Rising Adoption of Non-Invasive Diagnostic Imaging Technologies”

• A significant and accelerating trend in the global Magnetic Resonance Elastography (MRE) market is the growing integration of advanced MRI imaging systems with non-invasive tissue stiffness assessment technologies for improved disease diagnosis and patient monitoring. This integration is significantly enhancing diagnostic precision and clinical efficiency across healthcare facilities
• For instance, Magnetic Resonance Elastography systems are increasingly being utilized for liver fibrosis evaluation and neurological disorder assessment through advanced MRI platforms capable of delivering detailed tissue elasticity measurements. Similarly, healthcare institutions are adopting integrated MRE solutions for improved detection of chronic liver diseases and tumor characterization
• Artificial intelligence integration in Magnetic Resonance Elastography (MRE) enables features such as automated image analysis, enhanced tissue characterization, and faster interpretation of diagnostic results. For instance, some advanced MRI platforms utilize AI-assisted algorithms to improve liver stiffness quantification accuracy and support clinicians in identifying abnormal tissue patterns more efficiently. Furthermore, advanced imaging capabilities offer healthcare professionals the ability to perform precise, non-invasive assessments without the need for surgical biopsies
• The seamless integration of Magnetic Resonance Elastography (MRE) with modern radiology workflows and hospital imaging infrastructure facilitates centralized diagnostic management across multiple clinical departments. Through integrated imaging platforms, healthcare providers can evaluate liver, breast, brain, and musculoskeletal disorders while improving workflow efficiency and patient outcomes
• This trend towards more advanced, accurate, and patient-friendly diagnostic imaging systems is fundamentally reshaping expectations for disease detection and monitoring. Consequently, companies such as Siemens Healthineers and GE HealthCare are developing enhanced MRI-based elastography systems with advanced imaging software and AI-enabled analysis capabilities for broader clinical applications
• The demand for Magnetic Resonance Elastography (MRE) systems offering accurate, non-invasive, and technologically advanced diagnostic capabilities is growing rapidly across hospitals and specialty imaging centers, as healthcare providers increasingly prioritize early disease detection and precision medicine approaches
• Growing collaborations between medical imaging companies and healthcare institutions for the development of advanced elastography software and next-generation MRI technologies are supporting continuous innovation and improving the overall diagnostic capabilities of Magnetic Resonance Elastography (MRE) systems

Magnetic Resonance Elastography (MRE) Market Dynamics

Driver

“Growing Demand Due to Rising Prevalence of Chronic Liver Diseases and Need for Non-Invasive Diagnostics”

• The increasing prevalence of chronic liver diseases, fibrosis, and cancer-related conditions, coupled with the rising preference for non-invasive diagnostic technologies, is a significant driver for the heightened demand for Magnetic Resonance Elastography (MRE) systems
• For instance, in March 2025, Siemens Healthineers announced advancements in MRI imaging technologies designed to improve elastography-based liver disease assessment and diagnostic workflow efficiency. Such strategies by key companies are expected to drive the Magnetic Resonance Elastography (MRE) industry growth in the forecast period
• As healthcare providers become more focused on early disease detection and accurate patient monitoring, Magnetic Resonance Elastography (MRE) offers advanced capabilities such as quantitative tissue stiffness measurement, non-invasive fibrosis staging, and improved diagnostic accuracy, providing a compelling alternative to traditional biopsy procedures
• Furthermore, the growing adoption of advanced imaging technologies and the increasing emphasis on precision medicine are making Magnetic Resonance Elastography (MRE) an essential component of modern radiology practices, offering seamless integration with MRI platforms and hospital imaging systems
• The ability to perform painless, non-invasive tissue assessments, support disease monitoring, and reduce biopsy-related complications are key factors propelling the adoption of Magnetic Resonance Elastography (MRE) systems in hospitals and diagnostic imaging centers. The trend towards advanced healthcare infrastructure development and increasing awareness regarding early diagnosis further contribute to market growth
• The rising global burden of non-alcoholic fatty liver disease (NAFLD) and hepatitis-related disorders is further accelerating demand for Magnetic Resonance Elastography (MRE), as healthcare providers increasingly require reliable technologies for early fibrosis detection and long-term patient management
• Increasing investments in advanced diagnostic imaging infrastructure by hospitals, academic medical centers, and specialty clinics are supporting the broader deployment of Magnetic Resonance Elastography (MRE) systems across developed and emerging healthcare markets

Restraint/Challenge

“High Equipment Costs and Limited Accessibility Hurdle”

• Concerns surrounding the high installation and operational costs associated with advanced MRI systems and elastography technologies pose a significant challenge to broader market penetration. As Magnetic Resonance Elastography (MRE) requires specialized MRI equipment and trained professionals, accessibility remains limited in several healthcare settings, particularly in developing regions
• For instance, the substantial investment required for advanced MRI infrastructure and elastography software integration has made some smaller healthcare facilities hesitant to adopt Magnetic Resonance Elastography (MRE) systems despite their diagnostic advantages
• Addressing these cost and accessibility concerns through technological advancements, improved reimbursement frameworks, and streamlined imaging workflows is crucial for expanding adoption. Companies such as Philips Healthcare and Canon Medical Systems emphasize scalable imaging solutions and workflow optimization technologies to support broader clinical implementation. In addition, the relatively high maintenance and operational costs of MRI-based elastography systems compared to conventional diagnostic methods can be a barrier to adoption for budget-constrained healthcare providers, particularly in emerging markets or smaller diagnostic centers
• While healthcare investments are gradually increasing, the perceived financial burden associated with advanced imaging technologies can still hinder widespread adoption, especially for facilities with limited radiology budgets or lower patient volumes
• Overcoming these challenges through cost-effective imaging innovations, expanded healthcare infrastructure, and increased awareness regarding the clinical benefits of non-invasive diagnostics will be vital for sustained Magnetic Resonance Elastography (MRE) market growth
• The limited availability of skilled radiologists and imaging professionals trained in elastography interpretation can also restrict the effective implementation of Magnetic Resonance Elastography (MRE) technologies in certain healthcare facilities
• Variability in reimbursement policies and limited insurance coverage for advanced elastography procedures across several countries may further impact patient accessibility and slow the adoption of Magnetic Resonance Elastography (MRE) systems in cost-sensitive healthcare markets

Magnetic Resonance Elastography (MRE) Market Scope

The market is segmented on the basis of application and end user.

• By Application

On the basis of application, the Magnetic Resonance Elastography (MRE) market is segmented into hepatic magnetic resonance elastography, breast magnetic resonance elastography, brain magnetic resonance elastography, skeletal muscle magnetic resonance elastography, and others. The hepatic magnetic resonance elastography segment dominated the market with the largest market revenue share of 47.6% in 2025, driven by the increasing prevalence of chronic liver diseases, fibrosis, and cirrhosis globally. Healthcare providers widely utilize hepatic MRE as a reliable non-invasive alternative to liver biopsy for assessing liver stiffness and disease progression. The growing burden of non-alcoholic fatty liver disease (NAFLD) and hepatitis-related disorders has significantly accelerated the demand for hepatic elastography procedures across hospitals and diagnostic imaging centers. In addition, the high diagnostic accuracy and reproducibility offered by hepatic MRE systems support their increasing clinical adoption. Favorable clinical guidelines promoting non-invasive liver assessment methods further strengthen the segment’s dominance in the global market. Moreover, continuous advancements in MRI imaging technologies and AI-assisted liver analysis solutions are contributing to improved patient outcomes and workflow efficiency.

The brain magnetic resonance elastography segment is anticipated to witness the fastest growth rate from 2026 to 2033, fueled by increasing research activities focused on neurological disorders and brain tissue characterization. Brain MRE is gaining substantial attention for its ability to evaluate tissue stiffness changes associated with neurodegenerative diseases, tumors, and traumatic brain injuries. Growing investments in advanced neurological imaging technologies and rising awareness regarding early diagnosis of brain-related disorders are further supporting market growth. Research institutes and academic medical centers are increasingly adopting brain MRE systems to improve understanding of brain biomechanics and disease progression. In addition, the integration of artificial intelligence and advanced imaging software into neurological elastography applications is enhancing diagnostic precision and interpretation efficiency. The expanding use of non-invasive neuroimaging techniques in both clinical and research settings is expected to accelerate the adoption of brain magnetic resonance elastography globally.

• By End User

On the basis of end user, the Magnetic Resonance Elastography (MRE) market is segmented into hospitals, diagnostic imaging centers, research institutes, and others. The hospitals segment dominated the market with the largest market revenue share in 2025, driven by the increasing installation of advanced MRI systems and growing patient preference for comprehensive diagnostic services within hospital settings. Hospitals serve as primary healthcare centers for the diagnosis and management of chronic liver diseases, neurological disorders, and cancer-related conditions, resulting in high demand for MRE procedures. The availability of skilled radiologists, advanced imaging infrastructure, and integrated healthcare services further supports the widespread adoption of Magnetic Resonance Elastography systems in hospitals. In addition, increasing healthcare investments and rising focus on precision medicine are encouraging hospitals to expand their advanced diagnostic imaging capabilities. Hospitals also benefit from higher patient inflow and improved reimbursement support for non-invasive imaging procedures. Furthermore, collaborations between hospitals and medical imaging companies for the deployment of next-generation MRI technologies are strengthening the segment’s market position.

The diagnostic imaging centers segment is expected to witness the fastest CAGR from 2026 to 2033, driven by the growing demand for specialized and cost-effective diagnostic imaging services. Diagnostic imaging centers are increasingly adopting Magnetic Resonance Elastography systems to provide advanced liver, breast, brain, and musculoskeletal imaging procedures with improved patient convenience and shorter waiting times. The rising preference for outpatient diagnostic services and the increasing number of independent imaging facilities are further supporting segment growth. In addition, advancements in compact MRI technologies and workflow optimization solutions are enabling imaging centers to improve operational efficiency and patient throughput. Diagnostic imaging centers also offer flexible scheduling and faster diagnostic reporting, making them an attractive option for patients and healthcare providers. The expanding availability of specialized radiology services across emerging healthcare markets is expected to further accelerate the growth of the diagnostic imaging centers segment during the forecast period

Magnetic Resonance Elastography (MRE) Market Regional Analysis

• North America dominated the Magnetic Resonance Elastography (MRE) market with the largest revenue share of 41.3% in 2025, supported by advanced healthcare infrastructure, widespread adoption of MRI technologies, and the strong presence of leading medical imaging companies
• Healthcare providers in the region highly value the diagnostic accuracy, non-invasive assessment capabilities, and advanced imaging integration offered by Magnetic Resonance Elastography (MRE) systems for evaluating liver, brain, and musculoskeletal disorders
• This widespread adoption is further supported by advanced healthcare infrastructure, strong healthcare expenditure, and the presence of leading medical imaging companies, establishing Magnetic Resonance Elastography (MRE) as a preferred diagnostic solution across hospitals, diagnostic imaging centers, and research institutions

U.S. Magnetic Resonance Elastography (MRE) Market Insight

The U.S. Magnetic Resonance Elastography (MRE) market captured the largest revenue share in 2025 within North America, fueled by the growing prevalence of chronic liver diseases and the increasing adoption of advanced diagnostic imaging technologies. Healthcare providers are increasingly prioritizing non-invasive diagnostic procedures for accurate assessment of liver fibrosis, neurological disorders, and cancer-related conditions. The growing preference for precision medicine approaches, combined with robust investments in advanced MRI infrastructure and AI-assisted imaging technologies, further propels the Magnetic Resonance Elastography (MRE) industry. Moreover, the increasing integration of advanced MRI systems with elastography software and digital healthcare platforms is significantly contributing to the market's expansion.

Europe Magnetic Resonance Elastography (MRE) Market Insight

The Europe Magnetic Resonance Elastography (MRE) market is projected to expand at a substantial CAGR throughout the forecast period, primarily driven by increasing healthcare investments and the escalating demand for non-invasive diagnostic imaging solutions. The rise in chronic liver diseases and neurological disorders, coupled with the growing adoption of advanced MRI technologies, is fostering the utilization of Magnetic Resonance Elastography systems. European healthcare providers are also drawn to the high diagnostic accuracy and patient-friendly nature these technologies offer. The region is experiencing significant growth across hospitals, diagnostic imaging centers, and research institutions, with Magnetic Resonance Elastography (MRE) systems being increasingly incorporated into modern radiology practices and clinical research programs.

U.K. Magnetic Resonance Elastography (MRE) Market Insight

The U.K. Magnetic Resonance Elastography (MRE) market is anticipated to grow at a noteworthy CAGR during the forecast period, driven by the increasing focus on early disease diagnosis and the rising demand for advanced non-invasive imaging technologies. In addition, concerns regarding chronic liver disease prevalence and neurological health conditions are encouraging healthcare providers to adopt advanced elastography-based diagnostic solutions. The U.K.’s growing emphasis on digital healthcare transformation, alongside its strong healthcare infrastructure and research capabilities, is expected to continue to stimulate market growth.

Germany Magnetic Resonance Elastography (MRE) Market Insight

The Germany Magnetic Resonance Elastography (MRE) market is expected to expand at a considerable CAGR during the forecast period, fueled by increasing awareness regarding advanced diagnostic imaging and the demand for technologically sophisticated healthcare solutions. Germany’s well-developed healthcare infrastructure, combined with its strong emphasis on medical innovation and research activities, promotes the adoption of Magnetic Resonance Elastography systems, particularly across hospitals and specialty imaging centers. The integration of Magnetic Resonance Elastography (MRE) with advanced MRI technologies is also becoming increasingly prevalent, with a strong preference for precise and non-invasive diagnostic methods aligning with local healthcare priorities.

Asia-Pacific Magnetic Resonance Elastography (MRE) Market Insight

The Asia-Pacific Magnetic Resonance Elastography (MRE) market is poised to grow at the fastest CAGR during the forecast period of 2026 to 2033, driven by increasing healthcare expenditure, rising patient population, and expanding access to advanced diagnostic imaging technologies in countries such as China, Japan, and India. The region's growing focus on early disease detection and healthcare modernization, supported by government initiatives promoting healthcare infrastructure development, is driving the adoption of Magnetic Resonance Elastography systems. Furthermore, as Asia-Pacific emerges as a major healthcare technology market, the accessibility and availability of advanced MRI and elastography systems are expanding across a broader network of hospitals and diagnostic imaging centers.

Japan Magnetic Resonance Elastography (MRE) Market Insight

The Japan Magnetic Resonance Elastography (MRE) market is gaining momentum due to the country’s advanced healthcare infrastructure, strong focus on medical innovation, and growing demand for precision diagnostic technologies. The Japanese healthcare sector places significant emphasis on early disease detection, and the adoption of Magnetic Resonance Elastography systems is driven by the increasing prevalence of liver and neurological disorders. The integration of Magnetic Resonance Elastography (MRE) with advanced MRI imaging platforms and AI-assisted diagnostic technologies is fueling market growth. Moreover, Japan's aging population is expected to spur demand for accurate, non-invasive diagnostic solutions across hospitals and specialty healthcare facilities.

India Magnetic Resonance Elastography (MRE) Market Insight

The India Magnetic Resonance Elastography (MRE) market accounted for the largest market revenue share in Asia Pacific in 2025, attributed to the country's expanding healthcare infrastructure, rising prevalence of chronic liver diseases, and increasing adoption of advanced diagnostic imaging technologies. India stands as one of the rapidly growing healthcare markets, and Magnetic Resonance Elastography systems are becoming increasingly utilized across hospitals, diagnostic imaging centers, and research institutions. The push towards healthcare modernization and the increasing availability of advanced MRI technologies, alongside growing investments by healthcare providers, are key factors propelling the Magnetic Resonance Elastography (MRE) market in India

Magnetic Resonance Elastography (MRE) Market Share

The Magnetic Resonance Elastography (MRE) industry is primarily led by well-established companies, including:

• GE HealthCare (U.S.)
• Siemens Healthineers AG (Germany)
• Koninklijke Philips N.V. (Netherlands)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• FUJIFILM Holdings Corporation (Japan)
• Shimadzu Corporation (Japan)
• Hitachi, Ltd. (Japan)
• Hologic, Inc. (U.S.)
• Bruker Corporation (U.S.)
• Esaote S.p.A. (Italy)
• Resoundant, Inc. (U.S.)
• MR Solutions Ltd (U.K.)
• Time Medical Holding (China)
• Synaptive Medical Inc. (Canada)
• Aspect Imaging Ltd. (Israel)
• Hyperfine, Inc. (U.S.)
• Neusoft Medical Systems Co., Ltd. (China)
• Mediso Ltd. (Hungary)
• Aurora Imaging Technology, Inc. (U.S.)
• United Imaging Healthcare Co., Ltd. (China)

What are the Recent Developments in Global Magnetic Resonance Elastography (MRE) Market?

• In November 2025, GE HealthCare introduced its next-generation SIGNA MRI technology portfolio, including the SIGNA Bolt 3T MRI scanner and SIGNA Sprint system with AI-driven workflow capabilities. These systems are designed to enhance precision diagnostics, improve imaging efficiency, and support advanced MRI research applications, contributing to the advancement of Magnetic Resonance Elastography (MRE) technologies and high-performance non-invasive imaging solutions
• In October 2025, researchers published a major advancement in brain Magnetic Resonance Elastography (MRE) involving a real-time nonlinear inversion framework powered by operator learning and artificial intelligence. The development demonstrated substantial improvements in imaging speed and spatial accuracy for brain elastography analysis, supporting faster and more reliable assessment of neurological disorders and expanding future clinical applications of Magnetic Resonance Elastography (MRE)
• In July 2025, Philips received FDA 510(k) clearance for its SmartSpeed Precise dual AI MRI software designed to accelerate MRI scanning and improve image quality across 1.5T and 3.0T MRI systems. The software supports enhanced diagnostic workflows and more efficient imaging processes, strengthening the development of advanced MRI applications, including Magnetic Resonance Elastography (MRE) for liver and neurological disease assessment
• In February 2025, Philips announced the launch of its SmartSpeed Precise MRI technology powered by dual AI engines to improve imaging speed, precision, and workflow efficiency across MRI applications, including advanced elastography and non-invasive diagnostic imaging. The technology enables up to three times faster scans with enhanced image sharpness, supporting improved patient outcomes and greater adoption of advanced MRI-based diagnostic procedures such as Magnetic Resonance Elastography (MRE)
• In January 2025, Siemens Healthineers unveiled a new portfolio of advanced MRI technologies and AI-powered imaging solutions during AOCR 2025 in Chennai, aimed at improving precision diagnostics and expanding access to advanced MRI procedures. The company highlighted innovations supporting improved imaging efficiency, sustainable MRI operations, and broader clinical applications relevant to Magnetic Resonance Elastography (MRE) and other non-invasive imaging techniques

SKU-54501